Clinical trial
Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)
NCT00483730 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00483730 |
|---|---|
| Title | Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) |
| Official title | A Multi-centre, Double-blind, Placebo-controlled, Randomised, Parallel Group Clinical Trial to Evaluate Efficacy and Safety of Actovegin® in Diabetic Type 2 Patients With Symptomatic Diabetic Peripheral Polyneuropathy |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Symptomatic Diabetic Peripheral Polyneuropathy |
| Intervention type | Drug |
| Interventions | Deproteinised hemoderivative of calf blood (Actovegin) |
| Enrollment | 569 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 7, 2007 |
| Last update posted | May 7, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: